About: http://webisa.webdatacommons.org/451207805

Property	Value
http://www.w3.org/1999/02/22-rdf-syntax-ns#type	http://www.w3.org/ns/prov#Entity
http://www.w3.org/ns/prov#value	AnaptysBio is exploiting the SHM-XEL platform to develop an in house pipeline of therapeutic antibodies for autoimmune diseases, cancer and other disorders, and also through collaborations.
http://www.w3.org/ns/prov#wasQuotedFrom	genengnews.com